Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A14107 | 29579601 | Int J Cardiol | Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis. | 2018 | Details |
| A14130 | 29571977 | Diabetes Metab Syndr | Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors. | 2018 | Details |
| A14142 | 29565984 | PLoS One | Severity of nonalcoholic fatty liver disease is associated with subclinical cerebro-cardiovascular atherosclerosis risk in Korean men. | 2018 | Details |
| A14168 | 29555504 | Eur J Pharmacol | Alantolactone suppresses APOC3 expression and alters lipid homeostasis in L02 liver cells. | 2018 | Details |
| A14181 | 29547708 | Atherosclerosis | Resolution of fatty liver and weight loss: Independent associations with changes in serum lipids and apolipoproteins. | 2018 | Details |
| A14182 | 29547706 | Atherosclerosis | Clinical implications of current cardiovascular outcome trials with sodium glucose cotransporter-2 (SGLT2) inhibitors. | 2018 | Details |
| A14191 | 29537411 | J R Coll Physicians Edinb | Bariatric surgery as a treatment for metabolic syndrome. | 2017 | Details |
| A14200 | 29529073 | PLoS One | Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort. | 2018 | Details |
| A14205 | 29527140 | Clin Proteomics | Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease. | 2018 | Details |
| A14218 | 29519663 | Surg Obes Relat Dis | Patients with clinically metabolically healthy obesity are not necessarily healthy subclinically: further support for bariatric surgery in patients without metabolic disease? | 2017 | Details |
| A14222 | 29517842 | Liver Int | Serum testosterone and non-alcoholic fatty liver disease in men and women in the US. | 2018 | Details |
| A14224 | 29516496 | J Physiol | Primate fetal hepatic responses to maternal obesity: epigenetic signalling pathways and lipid accumulation. | 2018 | Details |
| A14235 | 29511882 | Curr Atheroscler Rep | Cardiometabolic Effects of Anti-obesity Pharmacotherapy. | 2018 | Details |
| A14240 | 29509436 | Am J Physiol Endocrinol Metab | Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease. | 2018 | Details |
| A14252 | 29505475 | Eur J Gastroenterol Hepatol | De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients. | 2018 | Details |
| A14254 | 29503789 | Curr Hepatol Rep | Managing the Burden of Non-NASH NAFLD. | 2017 | Details |
| A14262 | 29497497 | F1000Res | The role of NAFLD in cardiometabolic disease: an update. | 2018 | Details |
| A14268 | 29492830 | Clin J Gastroenterol | The genetic backgrounds in nonalcoholic fatty liver disease. | 2018 | Details |
| A14277 | 29487137 | Genetics | Seven-Up Is a Novel Regulator of Insulin Signaling. | 2018 | Details |
| A14285 | 29483369 | Biosci Rep | Maternal obesity increases the risk of metabolic disease and impacts renal health in offspring. | 2018 | Details |
| A14305 | 29225776 | F1000Res | The sedentary (r)evolution: Have we lost our metabolic flexibility? | 2017 | Details |
| A14310 | 29470816 | J Physiol Biochem | Hepatic subcellular distribution of squalene changes according to the experimental setting. | 2018 | Details |
| A14327 | 29463916 | Int J Obes (Lond) | Evaluating feasibility and accuracy of non-invasive tests for nonalcoholic fatty liver disease in severe and morbid obesity. | 2018 | Details |
| A14333 | 29462898 | Diseases | Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease? | 2018 | Details |
| A14337 | 29461236 | Georgian Med News | FEATURES OF EXCRETION OF MELATONIN IN URINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND NON-ALCOHOLIC FATTY LIVER DISEASE WITH MANIFESTATIONS OF FIBROSIS AND ITS RELATIONSHIP WITH CERTAIN METABOLIC AND IMMUNOLOGICAL INDICATORS. | 2018 | Details |
| A14349 | 29452601 | Cardiovasc Diabetol | Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. | 2018 | Details |
| A14366 | 29445363 | Front Microbiol | Helicobacter pylori Infection Is Not Associated with Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study in China. | 2018 | Details |
| A14383 | 29434690 | Exp Ther Med | Changes in inflammatory factors and prognosis of patients complicated with non-alcoholic fatty liver disease undergoing coronary artery bypass grafting. | 2017 | Details |
| A14388 | 29431526 | Expert Rev Gastroenterol Hepatol | The potential role of statins in treating liver disease. | 2018 | Details |
| A14391 | 29430321 | Liver Res | Interaction between stress responses and circadian metabolism in metabolic disease. | 2017 | Details |
| A14400 | 29427492 | Liver Int | Future therapy for non-alcoholic fatty liver disease. | 2018 | Details |
| A14423 | 29413998 | Curr Opin Pharmacol | Lipid-lowering treatment in peripheral artery disease. | 2018 | Details |
| A14441 | 29405466 | J Gastroenterol Hepatol | Prediction of carotid intima-media thickness in obese patients with low prevalence of comorbidities by serum copper bioavailability. | 2018 | Details |
| A14444 | 29404514 | Hepatol Commun | Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice. | 2017 | Details |
| A14448 | 29404500 | Hepatol Commun | Progression of liver fibrosis is associated with non-liver-related mortality in patients with nonalcoholic fatty liver disease. | 2017 | Details |
| A14457 | 29402657 | Diabetes Metab Syndr | Nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and its association with cardiovascular disease. | 2018 | Details |
| A14471 | 29398414 | Dig Liver Dis | Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects. | 2017 | Details |
| A14477 | 29393027 | Ugeskr Laeger | [Controlled attenuation parameter is a novel technique in screening for non-alcoholic fatty liver disease]. | 2018 | Details |
| A14483 | 29390925 | Crit Rev Clin Lab Sci | Diagnostic criteria and contributors to Gilbert's syndrome. | 2018 | Details |
| A14484 | 29390103 | Nephrol Dial Transplant | Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease. | 2019 | Details |
| A14490 | 29385682 | Nutrients | Serum Antioxidant Associations with Metabolic Characteristics in Metabolically Healthy and Unhealthy Adolescents with Severe Obesity: An Observational Study. | 2018 | Details |
| A14508 | 29377201 | Ann N Y Acad Sci | Cardiometabolic risk in obese children. | 2018 | Details |
| A14517 | 29372507 | Hepatol Int | Repeated liver stiffness measurement compared with paired liver biopsy in patients with non-alcoholic fatty liver disease. | 2018 | Details |
| A14546 | 29359590 | Arch Physiol Biochem | Association of carotid intima media thickness with atherogenic index of plasma, apo B/apo A-I ratio and paraoxonase activity in patients with non-alcoholic fatty liver disease. | 2018 | Details |
| A14550 | 29358945 | PPAR Res | Peroxisome Proliferator-Activated Receptors Associated with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A14565 | 29351427 | Am J Physiol Regul Integr Comp Physiol | Role of PTP1B in POMC neurons during chronic high-fat diet: sex differences in regulation of liver lipids and glucose tolerance. | 2017 | Details |
| A14566 | 29351115 | Eur J Gastroenterol Hepatol | Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease: a meta-analysis. | 2018 | Details |
| A14586 | 29337849 | Antioxidants (Basel) | Vitamin E as a Treatment for Nonalcoholic Fatty Liver Disease: Reality or Myth? | 2018 | Details |
| A14594 | 29334743 | Vnitr Lek | [Adiponectin in patients with metabolic syndrome and diseases of the liver, bile ducts and pancreas]. | 2018 | Details |
| A14616 | 29322544 | Aliment Pharmacol Ther | Role of bisphenol A as environmental factor in the promotion of non-alcoholic fatty liver disease: in vitro and clinical study. | 2018 | Details |
| A14633 | 29315155 | Eur J Gastroenterol Hepatol | Association of the ideal cardiovascular behaviors and factors with the incidence of nonalcoholic fatty liver disease: a prospective study. | 2018 | Details |
| A14638 | 29313571 | J Assoc Physicians India | A Study of Endothelial Dysfunction in Patients of Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A14648 | 29309395 | Eur J Gastroenterol Hepatol | The association of fatty pancreas with subclinical atherosclerosis in nonalcoholic fatty liver disease. | 2018 | Details |
| A14688 | 29288403 | Heart Vessels | The impact of non-alcoholic fatty liver disease fibrosis score on cardiac prognosis in patients with chronic heart failure. | 2017 | Details |
| A14692 | 29287685 | Pharmacol Res | Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review. | 2017 | Details |
| A14698 | 29286050 | Nat Rev Endocrinol | Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. | 2017 | Details |
| A14699 | 29285942 | Orv Hetil | [Non-alcoholic fatty liver disease, as a component of the metabolic syndrome, and its causal correlations with other extrahepatic diseases]. | 2017 | Details |
| A14715 | 29274406 | J Hepatol | Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study. | 2017 | Details |
| A14720 | 29271970 | AIDS Rev | Non-Alcoholic Fatty Liver Disease and HIV/AIDS: A New Way of Modulation of Cardiovascular Risk. | 2018 | Details |
| A14739 | 29264555 | J Endocr Soc | Nonalcoholic Fatty Liver Disease in Hispanic Youth With Dysglycemia: Risk for Subclinical Atherosclerosis? | 2017 | Details |
| A14771 | 29247356 | J Gastroenterol | Current and future pharmacological therapies for NAFLD/NASH. | 2017 | Details |
| A14789 | 29232562 | Atherosclerosis | TM6SF2: A novel target for plasma lipid regulation. | 2017 | Details |
| A14795 | 29228164 | Eur Heart J | Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals. | 2018 | Details |
| A14799 | 29226105 | J Clin Transl Hepatol | Non-alcoholic Fatty Liver Disease: A Clinical Update. | 2017 | Details |
| A14803 | 29224471 | Expert Rev Gastroenterol Hepatol | Clinical relevance of liver histopathology and different histological classifications of NASH in adults. | 2017 | Details |
| A14804 | 29224108 | Adv Exp Med Biol | Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men. | 2017 | Details |
| A14805 | 29224098 | Adv Exp Med Biol | Role of Estrogens in the Regulation of Liver Lipid Metabolism. | 2017 | Details |
| A14836 | 29210656 | Curr Vasc Pharmacol | Editorial: Arterial Stiffness, Central Haemodynamics and Non-Alcoholic Fatty Liver Disease: Links with Cardiovascular Risk and Effects of Drug Treatment. | 2018 | Details |
| A14839 | 29209995 | Diabetes Ther | Early Clinical Expressions of Insulin Resistance: The Real Enemy to Look For. | 2017 | Details |
| A14867 | 29199410 | Diabetes Metab J | Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases. | 2017 | Details |
| A14875 | 29197188 | FEBS J | Genipin alleviates high-fat diet-induced hyperlipidemia and hepatic lipid accumulation in mice via miR-142a-5p/SREBP-1c axis. | 2017 | Details |
| A14889 | 29189999 | J Endocrinol Invest | NAFLD/NASH in patients with type 2 diabetes and related treatment options. | 2017 | Details |
| A14891 | 29189176 | Rev Recent Clin Trials | The Emerging Role of Complement C3 as A Biomarker of Insulin Resistance and Cardiometabolic Diseases: Preclinical and Clinical Evidence. | 2018 | Details |
| A14892 | 29189132 | Curr Pharm Des | Polyphenols: Novel Signaling Pathways. | 2018 | Details |
| A14898 | 29184449 | HIV AIDS (Auckl) | Diabetes, metabolic syndrome and dyslipidemia in people living with HIV in Africa: re-emerging challenges not to be forgotten. | 2017 | Details |
| A14901 | 29183220 | Phys Sportsmed | The effect of low volume sprint interval training in patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A14909 | 29177681 | J Gastroenterol | Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods. | 2017 | Details |
| A14910 | 29177105 | J Clin Cell Immunol | Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis. | 2017 | Details |
| A14914 | 29175651 | Atherosclerosis | Subclinical cerebrovascular disease in NAFLD without overt risk factors for atherosclerosis. | 2017 | Details |
| A14916 | 29175242 | J Hepatol | Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients. | 2017 | Details |
| A14922 | 29172017 | Med Sci Monit | Scutellarin Prevents Nonalcoholic Fatty Liver Disease (NAFLD) and Hyperlipidemia via PI3K/AKT-Dependent Activation of Nuclear Factor (Erythroid-Derived 2)-Like 2 (Nrf2) in Rats. | 2017 | Details |
| A14925 | 29170905 | Endocrine | Irisin in metabolic diseases. | 2017 | Details |
| A14931 | 29167659 | Front Microbiol | Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota. | 2017 | Details |
| A14934 | 29167212 | Diabetes Care | Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission. | 2017 | Details |
| A14944 | 29162773 | J Atheroscler Thromb | A High-Fat and High-Cholesterol Diet Induces Cardiac Fibrosis, Vascular Endothelial, and Left Ventricular Diastolic Dysfunction in SHRSP5/Dmcr Rats. | 2017 | Details |
| A14949 | 29159396 | JAMA Neurol | Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study. | 2018 | Details |
| A14954 | 29158157 | Clin Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not Men. | 2017 | Details |
| A14975 | 29149647 | J Nutr Biochem | Dietary fish oil differentially ameliorates high-fructose diet-induced hepatic steatosis and hyperlipidemia in mice depending on time of feeding. | 2017 | Details |
| A14978 | 29146119 | Diabetes Res Clin Pract | An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug's effect on cardiovascular disease and non-alcoholic steatohepatitis. | 2017 | Details |
| A14986 | 29138984 | Curr Hypertens Rep | 11β-Hydroxysteroid Dehydrogenases and Hypertension in the Metabolic Syndrome. | 2017 | Details |
| A15000 | 29129237 | Nutrition | Iron-induced pro-oxidant and pro-lipogenic responses in relation to impaired synthesis and accretion of long-chain polyunsaturated fatty acids in rat hepatic and extrahepatic tissues. | 2017 | Details |
| A15011 | 29128058 | Clin Liver Dis | Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation. | 2017 | Details |
| A15015 | 29128054 | Clin Liver Dis | The Role of Nonalcoholic Fatty Liver Disease on Cardiovascular Manifestations and Outcomes. | 2017 | Details |
| A15018 | 29128051 | Clin Liver Dis | The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View. | 2018 | Details |
| A15029 | 29124703 | Adv Exp Med Biol | Vitamin D, Cardiovascular Disease and Risk Factors. | 2017 | Details |
| A15039 | 29122390 | J Hepatol | Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence? | 2017 | Details |
| A15046 | 29119374 | J Nucl Cardiol | Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2017. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance. | 2017 | Details |
| A15063 | 29113510 | Diab Vasc Dis Res | Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases. | 2017 | Details |
| A15074 | 29108191 | Zhonghua Gan Zang Bing Za Zhi | [An interpretation of the AASLD practice guideline on the diagnosis and management of nonalcoholic fatty liver disease in 2017]. | 2017 | Details |
| A15097 | 29098111 | Liver Res | Bile acid receptors link nutrient sensing to metabolic regulation. | 2017 | Details |